ORGO (Organogenesis Holdings) Cyclically Adjusted Book per Share: $3.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORGO Organogenesis Holdings Inc ORGO
62 GF Score
Price $1.86
GF Value $3.04
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Organogenesis Holdings Cyclically Adjusted Book per Share?

Organogenesis Holdings ORGO +3.92% 62 Cyclically Adjusted Book per Share is $3.11 as of Jun. 2026. GuruFocus rates ORGO with a GF Score™ of 62/100 and a GF Value™ of $3.04 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Organogenesis Holdings's adjusted book value per share for the three months ended in Jun. 2026 was $1.152. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.11 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-19), Organogenesis Holdings's current stock price is $1.855. Organogenesis Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $3.11. Organogenesis Holdings's Cyclically Adjusted PB Ratio of today is 0.60.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Organogenesis Holdings was 2.01. The lowest was 0.57. And the median was 0.87.


Organogenesis Holdings  (NAS:ORGO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Organogenesis Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.855/3.11
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Organogenesis Holdings was 2.01. The lowest was 0.57. And the median was 0.87.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Organogenesis Holdings Cyclically Adjusted Book per Share Related Terms


Organogenesis Holdings Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Organogenesis Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organogenesis Holdings Cyclically Adjusted Book per Share Chart

Organogenesis Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 3.02

Organogenesis Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.04 3.02 3.05 3.11

ORGO vs AKBA, TKNO, EBS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Organogenesis Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organogenesis Holdings Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organogenesis Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Organogenesis Holdings's Cyclically Adjusted PB Ratio falls into.


ORGO
62GF Score
Organogenesis Holdings Inc ORGO
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organogenesis Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Organogenesis Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.152/333.9520*333.9520
=1.152

Current CPI (Jun. 2026) = 333.9520.

Organogenesis Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201609 -0.004 241.428 -0.006
201612 7.745 241.432 10.713
201703 7.748 243.801 10.613
201706 7.758 244.955 10.577
201709 7.704 246.819 10.424
201712 -0.221 246.524 -0.299
201803 7.687 249.554 10.287
201806 7.696 251.989 10.199
201809 8.235 252.439 10.894
201812 0.515 251.233 0.685
201903 0.357 254.202 0.469
201906 0.254 256.143 0.331
201909 0.135 256.759 0.176
201912 0.530 256.974 0.689
202003 0.382 258.115 0.494
202006 0.339 257.797 0.439
202009 0.609 260.280 0.781
202012 1.110 260.474 1.423
202103 1.228 264.877 1.548
202106 1.395 271.696 1.715
202109 1.471 274.310 1.791
202112 1.875 278.802 2.246
202203 1.887 287.504 2.192
202206 1.944 296.311 2.191
202209 1.958 296.808 2.203
202212 2.029 296.797 2.283
202303 2.010 301.836 2.224
202306 2.066 305.109 2.261
202309 2.108 307.789 2.287
202312 2.122 306.746 2.310
202403 2.098 312.332 2.243
202406 1.988 314.175 2.113
202409 2.101 315.301 2.225
202412 2.091 315.605 2.213
202503 1.915 319.799 2.000
202506 1.839 322.561 1.904
202509 2.010 324.800 2.067
202512 2.364 324.054 2.436
202603 1.901 330.213 1.923
202606 1.152 333.952 1.152

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $3.11 mean?
Organogenesis Holdings (ORGO) has a Cyclically Adjusted Book per Share of $3.11 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Organogenesis Holdings and its competitors.
Is Organogenesis Holdings' Cyclically Adjusted Book per Share too high?
Organogenesis Holdings' current Cyclically Adjusted Book per Share is $3.11. Overall, Organogenesis Holdings has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organogenesis Holdings' Cyclically Adjusted Book per Share compare to AKBA and TKNO?
Organogenesis Holdings' Cyclically Adjusted Book per Share of $3.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Organogenesis Holdings and its competitors. Organogenesis Holdings's current Cyclically Adjusted Book per Share is $3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organogenesis Holdings stock overvalued right now?
Based on GuruFocus' analysis, Organogenesis Holdings (ORGO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.04, compared to a current price of $1.86 — trading 39% below its estimated fair value. The current Cyclically Adjusted Book per Share is $3.11. Organogenesis Holdings' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Organogenesis Holdings (ORGO), the current Cyclically Adjusted Book per Share is $3.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organogenesis Holdings (ORGO) Overvalued in 2026?

Based on GuruFocus' analysis, Organogenesis Holdings stock appears to be undervalued. The current stock price of $1.86 is trading 39% below its estimated GF Value™ of $3.04. GuruFocus considers Organogenesis Holdings to be Possible Value Trap.

Key valuation signals for ORGO:

  • Cyclically Adjusted Book per Share: $3.11
  • GF Value™: $3.04 vs. price of $1.86 (39% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the ORGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organogenesis Holdings Business Description

Other Exchanges 2PQ:Germany
Address 85 Dan Road, Canton, MA, USA, 02021
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
62GF Score

Get the complete analysis for ORGO

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.86
Price
$3.04
GF Value